Opens in a new tab

PONTIS BIOLOGICS INC.

Using mechanistic insights to design products to improve oral health.

Understand tartar development.

Learn More
Tartar-Degrading Formulation with a U.S. Patent

Revolutionizing Oral Care with Our Tartar-Degrading Formulation

Tartar is the one common dental problem you cannot address at home. We are finally changing that reality. Pontis Biologics, Inc. has invented a revolutionary oral health product that actively degrades dental tartar. Our patented tartar-degrading formulation provides a safe solution for daily hygiene. 

Clinical Results

Our published proof-of-principle clinical trial demonstrated that our unique formulation works remarkably well. We achieved a 40% reduction in existing tartar in just four weeks using our formulation. In contrast, the control group experienced a 12% increase. This groundbreaking success, achieved with our specific tartar-degrading formulation, was published in a peer-reviewed, open-access journal. 

Access the Journal

The Science Behind Tartarase

Like rebar in reinforced concrete, DNA and proteins are the matrix that supports the development of tartar. The only safe way to cut these matrix molecules is with enzymes found in Tartarase, a Pontis Biologics, Inc. product under the cosmetics pathway. We are also doing developmental work to improve our product and generate an analogous one for the veterinary market. 

Contact Us

Credibility

BMC Oral Health 2024 // U.S. Patent 12,478,571 B2 // Granted in Canada // Cornell PhD // Principal Investigator, Division of Endocrinology, Stony Brook University // 33 Publications. 

Science

Dennis Mynarcik, PhD

Founder and Inventor

Barbara Mish

Analytical and Formulations

Business

Miguel Titarelli

CEO

Tanuj Mehra

Senior Advisor
Secret Link